Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $51.31 -0.27%
EPS Growth %: -34.9%
Financial Fact:
Interest income: 110K
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: -34.9%
Financial Fact:
Interest income: 110K
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 EPS of $13.54. Revenue for the quarter came in at $69.8 million.
For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Okta set to join S&P 500, Glaukos to join S&P MidCap 400, McGrath RentCorp to join S&P SmallCap 600
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
